Antisense and RNAi Therapeuticst Market Research: Innovative Methodologies and Emerging Trends
Overview
The Global Antisense and RNAi Therapeutics Market is expected to be valued USD 5.5 billion in 2024 and is anticipated to reach USD 27.2 billion by 2033 at a CAGR of 19.4%.
The Antisense and RNAi therapeutics market represents a dynamic and rapidly evolving segment of the biotechnology industry. These therapies involve the use of synthetic nucleic acids to target and modulate gene expression, offering promising treatments for a wide range of diseases, including genetic disorders, cancer, and viral infections.